Characterization of signaling function and expression of HLA class I molecules in medulloblastoma.
J. Neurooncol., Jun;103(2):197-206 (2011)
Secretome signature of invasive glioblastoma multiforme.
J. Proteome Res., Jul;10(7):3149-59 (2011)
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.
J. Clin. Oncol., Feb;26(6):919-24 (2008)
Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.
Clin. Cancer Res., Jun;14(11):3386-94 (2008)
Aggressive infantile embryonal tumors.
J. Child Neurol., Oct;23(10):1195-204 (2008)
IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK.
J. Child Neurol., Oct;23(10):1205-13 (2008)
Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors.
J. Neurooncol., Oct;95(1):49-60 (2009)
Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
Mol. Cancer Ther., May;8(5):1137-47 (2009)
Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells.
J. Neurooncol., Jan;101(2):215-26 (2011)
Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
Oncologist., 8(2):174-86 (2003)
Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling.
Cancer Res., Apr;63(8):1865-70 (2003)
Medulloblastoma: present concepts of stratification into risk groups.
Pediatr Neurosurg., Jul;39(2):60-7 (2003)
The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma.
Pediatr Neurosurg., Jul;39(2):68-74 (2003)
Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches.
J. Neurooncol., Dec;75(3):267-72 (2005)
Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
Cancer., Dec;104(12):2862-71 (2005)
CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis.
Neurology., May;68(20):1668-73 (2007)
Medulloblastoma in childhood: new biological advances.
Lancet Neurol., Dec;6(12):1073-85 (2007)
Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.
Proteomics., Mar;11(5):935-43 (2011)
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.
Cancer Biol. Ther., Nov;12(9):818-26 (2011)
A novel role of HLA class I in the pathology of medulloblastoma.
J Transl Med., 7:59 (2009)